KMT2A-r AML also shows upregulation of HOXA cluster genes (Bourgeois et al., 2024), and HOXA10 is a target of KMT2A-fusions (Di Mambro et al., 2023). The gene discussed is KMT2A; the disease is acute myeloid leukemia.